Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Prediction of short-term and long-term responses to cladribine in relapsing-remitting multiple sclerosis: a Danish nationwide real-world study.
Determining the minimal important difference of EQ-5D-5 L utility values in CIDP patients using data from a large clinical trial.
DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.
Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.
Myelin oligodendrocyte glycoprotein antibody-associated isolated seizures in children: a retrospective single-center case series.
Cost-effectiveness of cladribine tablets for the treatment of active relapsing-remitting multiple sclerosis in the United Kingdom.
Editorial for "Multi-Parametric Phase-Cycled Balanced Steady-State Free Precession Brain Tissue Characterization in Relapsing-Remitting Multiple Sclerosis".
Multi-Parametric Phase-Cycled Balanced Steady-State Free Precession Brain Tissue Characterization in Relapsing-Remitting Multiple Sclerosis.
The Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.
Reply to 'Vitamin D status confounds urinary myelin basic protein in paediatric overactive bladder'.
Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications.
Divergent Trends in Relapse Activity and Relapse-Independent Progression Over Two Decades in Multiple Sclerosis.
Cholesterol dysregulation and microglial NLRP3 inflammasome activation after ischemic stroke: implications for neuroinflammation and functional recovery.
Efgartigimod for acute attacks of brainstem MOGAD followed by mycophenolate mofetil maintenance: a case report.
F-Wave-Induced Repetitive Discharges: Expanding the Spectrum of Stimulus-Induced Repetitive Discharges.
Corrigendum to "Video-based 2D markerless gait analysis in people with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 112, 107285].
Corrigendum to "Prognostic effect of serum glial fibrillary acidic protein and neurofilament light chain for predicting progression independent of relapse activity in multiple sclerosis: A systematic review" [Multiple Sclerosis and Related Disorders 114 (
Erratum to "Tolebrutinib liver safety: A detailed overview" [Multiple Sclerosis and Related Disorders 113 (2026) 107404].
Precision Nanomedicine for Traumatic Neural Injury: Functional Paradigms and Translational Frameworks.
Single cell landscape of sex differences in the different courses of multiple sclerosis.
Design, reporting, and research focus of neurology and psychiatry drug trials (2020-2023): a registry-based meta-epidemiological study using ClinicalTrials.gov and NLP.
Hepatic Orosomucoid 2 aggravates demyelination and drives microglial DAM-like activation.
Spectrum, management, and outcomes of non-obstetric neurological disorders in pregnancy: a descriptive case series from a tertiary centre in India.
Clinical heterogeneity in chronic inflammatory demyelinating polyneuropathy: data-driven subtypes challenge current classification.
Serine protease inhibitor A3 is a soluble SIRPα ligand that suppresses inflammation and antitumor immunity.

Pages